Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and Pazopanib in Biliary Tree Cancer
NCT01855724Phase 2Terminated
- Sponsor
- HeCOG
- Start
- Jun 2013
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pazopanib in biliary tract neoplasm, cholangiocarcinoma (CCA), gallbladder carcinoma, sponsored by HeCOG. Started Jun 2013; status: terminated.
02
Drugs
pazopanib
03
Conditions
biliary tract neoplasmcholangiocarcinoma (CCA)gallbladder carcinoma
Beyond the preview
Go deeper on NCT01855724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01855724.